Monthly Archives: October 2013

Study Finds Imprime PGG-bound Immune Cells Penetrate Tumor Microenvironment and Enhance Cancer Killing

EAGAN, MN — October 2, 2013 — Imprime PGG®, an immunomodulator, is able to enhance antitumor function of immune cells and direct a high percentage of these cells to the tumor microenvironment, according to in vivodata presented recently at the American Association for Cancer Research’s (AACR) Third International Conference on Frontiers in Basic Cancer Research in National Harbor, MD. Biothera researchers, in collaboration with the...

Read More